Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912.
作者信息
Shanafelt Tait D, Wang Xin Victoria, Hanson Curtis A, Paietta Elisabeth, O'Brien Susan, Barrientos Jacqueline, Jelinek Diane F, Braggio Esteban, Leis Jose F, Zhang Cong Christine, Barr Paul M, Cashen Amanda F, Mato Anthony R, Singh Avina K, Mullane Michael P, Little Richard F, Erba Harry, Stone Richard M, Litzow Mark, Tallman Martin, Kay Neil E
机构信息
Department of Medicine, Stanford University, Stanford CA.
Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA.
出版信息
Blood Adv. 2025 Jan 14;9(1):224-228. doi: 10.1182/bloodadvances.2024013474.
Abstract
摘要
Zotero 插件